PharmaShots | Incisive News in 3 Shots

Subscribe Now

PBKR03

Passage Bio Reports the First Patient Dosing of PBKR03 in the P-I/II (GALax-C) Trial for the Treatment of Infantile Krabbe Disease

Passage Bio Reports the First Patient Dosing of PBKR03 in the P-I/II (GALax-C) Trial for the Treatment of Infantile Krabbe Disease

March 11, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us